These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetics. SNP-ing drugs to size. Gura T Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082 [No Abstract] [Full Text] [Related]
3. Is there a role for nuclei in the metabolism of xenobiotica? A review. Romano M; Facchinetti T; Salmona M Drug Metab Rev; 1983; 14(4):803-29. PubMed ID: 6413186 [No Abstract] [Full Text] [Related]
4. Cytochrome P-450 mixed function oxygenases in isolated nuclei: relationship to chemical carcinogenesis. Gontovnick LS; Bellward GD Proc West Pharmacol Soc; 1980; 23():13-5. PubMed ID: 7403116 [No Abstract] [Full Text] [Related]
5. Interaction of chemical carcinogens and drug-metabolizing enzymes in primary cultures of hepatic cells from the rat. Michalopoulos G; Sattler G; Sattler C; Pitot HC Am J Pathol; 1976 Dec; 85(3):755-72. PubMed ID: 11697 [TBL] [Abstract][Full Text] [Related]
6. The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. Nebert DW; Jensen NM CRC Crit Rev Biochem; 1979; 6(4):401-37. PubMed ID: 378536 [No Abstract] [Full Text] [Related]
7. Genetic control of drug metabolism. Nebert DW Adv Exp Med Biol; 1978; 97():55-83. PubMed ID: 347904 [No Abstract] [Full Text] [Related]
8. Induction of drug metabolism: species differences and toxicological relevance. Graham MJ; Lake BG Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059 [TBL] [Abstract][Full Text] [Related]
9. Drug metabolism: speculations on the future. Bresnick E Drug Metab Rev; 1979; 10(2):311-3. PubMed ID: 551916 [No Abstract] [Full Text] [Related]
10. Investigation of the type of induction of microsomal monooxygenases by polycyclic hydrocarbons. Tsyrlov IB; Rivkind NB; Lyakhovich VV Biol Bull Acad Sci USSR; 1979; 6(1):28-34. PubMed ID: 549657 [TBL] [Abstract][Full Text] [Related]
11. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity. Oesch-Bartlomowicz B; Oesch F Biol Chem; 2002 Oct; 383(10):1587-92. PubMed ID: 12452435 [TBL] [Abstract][Full Text] [Related]
12. Induction of drug-metabolizing enzymes: mechanisms and consequences. Okey AB; Roberts EA; Harper PA; Denison MS Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989 [TBL] [Abstract][Full Text] [Related]
13. Cytochrome P-450: the Japanese connection. Gelboin HV Jpn J Cancer Res; 1993 Feb; 84(2):inside front cover. PubMed ID: 8463126 [No Abstract] [Full Text] [Related]
15. Drug-drug interactions: how scared should we be? Shapiro LE; Shear NH CMAJ; 1999 Nov; 161(10):1266-7. PubMed ID: 10584089 [No Abstract] [Full Text] [Related]
16. [Drug metabolism of the lung]. Yue TL Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):128-36. PubMed ID: 7433961 [No Abstract] [Full Text] [Related]
17. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs]. Ackermann E Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493 [No Abstract] [Full Text] [Related]
18. [Cytochrome P-450: the effect of drugs and poisons]. Chekman IS; Grinevich AI Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899 [No Abstract] [Full Text] [Related]
19. Effect of vitamin A deficiency on hepatic and intestinal drug metabolizing enzymes in rats. Gupta PH; Mehta S; Mehta SK Biochem Int; 1989 Jul; 19(1):123-33. PubMed ID: 2505773 [TBL] [Abstract][Full Text] [Related]
20. Omeprazole and aryl hydrocarbon hydroxylases: should we be worried? Kolars JC; Turgeon DK; Watkins PB Hepatology; 1991 Jan; 13(1):197-9. PubMed ID: 1988343 [No Abstract] [Full Text] [Related] [Next] [New Search]